Hem/Onc Pharmacology Section 18- Bortezomib and Carfilzomib

TOPICS: Carfilzomib, bortezomib, proteasome inhibitor, apoptosis, g2-m phase, multiple myeloma, mantle cell lymphoma, peripheral neuropathy, reactivation of herpes zoster, shingles, fatigue, dyspnea